The most important RNS yet for JLP:Jubilee Platinum, which up till now should only have been called Jubilee Chrome. This RNS has inserted the Platinum. It's been an 18 month wait since I invested, but it's worth it. The shares rocketed by 9.2% in the last 2.5 hours of trading after the news was published. The 5.55p bid price puts potential profit at £1,821 but it doesn't get a chance to re-take Star Share as IQE:IQE won't stop going up, and is at £2,514 potential profit.
I do have one slight concern, with interim results due out this week covering a period before any platinum was produced, and when chromite production at ASA was reduced in order to build new capacity for platinum enriched tailings storage. Any excuse for these shares to drop back to 5p seems to be embraced with open arms!
With gains this week from AMYT:Amryt Pharma too, things are going quite well. KIBO:Kibo Mining is determined to spoil things though, dropping even further to go £1,347 into loss and firmly consolidate the position of Nemesis Share.
The effect on the combined portfolios is an increase of £752 on last week and the portfolios £1,600 in the black. The combined ISA and share accounts have never been in the black on their own, but are now only 4.3% down. It's the SIPP being up 17.3% that's keeping the combined figure above water. We won't mention the 18.7% deficit in the trading account - that's the black sheep of the accounts but only has £1,000 in it.
There is one massive RNS tomorrow which is the AMYT:Amryt Pharma results. I don't know which way it will go, but doubt very much is will stay flat. This is such a big share in my portfolio that tiny changes have a huge impact.
If JLP:Jubilee Platinum also post an RNS tomorrow, that is likely to cause a big switch one way or the other too, whereas GVC:GVC Holdings going ex-dividend on a 12.5p divvy will knock at least £80 off the value, unless lots of people happen to buy in on the same day.
Just got to wait and see what happens...
No comments:
Post a Comment